Alerts will be sent to your verified email
Verify Email
VENUSREM
|
Venus Remedies
|
Sakar Healthcare
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.87 % | 8.14 % | 15.1 % |
|
5yr average Equity Multiplier
|
1.32 | 1.76 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.45 | 0.82 |
|
5yr Avg Net Profit Margin
|
6.91 % | 10.03 % | 14.59 % |
|
Price to Book
|
1.66 | 3.21 | 1.29 |
|
P/E
|
12.94 | 38.58 | 11.52 |
|
5yr Avg Cash Conversion Cycle
|
46.96 Days | 18.72 Days | -6.41 Days |
|
Inventory Days
|
75.64 Days | 51.79 Days | 43.91 Days |
|
Days Receivable
|
54.28 Days | 53.06 Days | 91.75 Days |
|
Days Payable
|
58.86 Days | 115.64 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
396.11 | 4.85 | 63.13 |
|
5yr Avg ROCE
|
8.42 % | 8.92 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
10.14 % | 24.94 % | 18.35 % |
|
5 yr average Debt to Equity
|
0.08 | 0.49 | 0.0 |
|
5yr CAGR Net Profit
|
-6.01 % | 10.38 % | 5.76 % |
|
5yr Average Return on Assets
|
6.69 % | 4.54 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.76 % | 52.86 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -9.24 % | 3.44 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venus Remedies
|
Sakar Healthcare
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|